Global, regional, and national levels and trends in older child, adolescent, and youth (5-24 years) all cause mortality from 1990 to 2024: modelling study
Listen to this summary
The authors aim to estimate and analyze all-cause mortality among individuals aged 5-24 years across 200 countries from 1990 to 2024, identifying trends and regions requiring urgent investment. Their findings indicate that while overall mortality in this age group has increased in significance, progress in reducing deaths has been uneven, particularly in high mortality regions like West and Central Africa. The study highlights the need for targeted interventions to address preventable deaths and improve mortality monitoring systems.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from BMJ (Clinical research ed.)
View all →Jun 24, 2026 · BMJ (Clinical research ed.)
Assessing early effects of Australia's Social Media Minimum Age Act on adolescents' social media use: observational study
Jun 18, 2026 · BMJ (Clinical research ed.)
Stereotactic radiotherapy for neovascular age related macular degeneration: year 3 and 4 extended follow up results of a randomised, double masked, sham controlled, device trial (STAR)
Jun 15, 2026 · BMJ (Clinical research ed.)
Advances in the development of malaria vaccines
Jun 11, 2026 · BMJ (Clinical research ed.)
Low concentration atropine eye drops and progression of myopia in children: multicentre placebo controlled, double masked, randomised trial in the UK (CHAMP-UK)
Jun 10, 2026 · BMJ (Clinical research ed.)
Advances in supporting development in autistic children and youth
Jun 8, 2026 · BMJ (Clinical research ed.)
Advances in the management of ADHD in children and adolescents
More in Internal Medicine
View all →Jun 25, 2026 · Blood
Combining Quizartinib with intensive chemotherapy in older patients with newly diagnosed AML: results of the UK NCRI AML18 Trial
Jun 25, 2026 · Blood
Translational Regulation of Sf1 Integrates Alternative Splicing and Hematopoietic Stem Cell Fate
Jun 25, 2026 · Blood
Galectin-1 Fuels Monocyte Hyperinflammation and Represents a Novel Therapeutic Target in Myeloproliferative Neoplasms
Jun 25, 2026 · The American journal of sports medicine
Association of Central Acetabular Osteophytes With Microinstability and Increased Combined Anteversion in Borderline Dysplasia Hips
Jun 25, 2026 · Blood
NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumab
Jun 24, 2026 · Lancet (London, England)
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


